Evaluation of patients admitted to our hospital with a possible diagnosis of COVID-19
Abstract views: 103 / PDF downloads: 87
Keywords:Covid-19, prognosis, diagnosis
We aimed to evaluate the clinical characteristics, laboratory and imaging findings, and outcomes associated with the severity of illness of patients admitted to our hospital with possible COVID-19 diagnosis. The patients admitted to our hospital with a possible diagnosis of COVID-19 between March 25 and December 3, 2020, were evaluated retrospectively. In terms of their clinical, laboratory, imaging findings, and mortality were compared between patients discharged and hospitalized with died and survivors. 12470 patients admitted to our hospital with a possible diagnosis of COVID-19 tested by SARS-CoV-2 RT-PCR. Of those tested, 3116 (24.9%) were positive. Of the patients, 2529 (81.2%) were discharged, 587 (18.8%) hospitalized, and 92 (3%) were died. In the comparison of discharged, and hospitalized groups, a significant difference was found in age, symptoms, comorbid diseases, chest CT, laboratory findings, and mortality (p< 0.05). In the comparison of survivor, and dead, the risk of mortality analysis showed similar characteristics. Older age, male gender, comorbidities, lymphopenia, thrombocytopenia, increased levels of CRP, NLR, D-dimer, ferritin, and chest CT findings were significant risk factors. Of the patients who died, 23 (25%) were female and 69 (75%) were male. The outbreak of COVID-19 is a significantly health problem. We were experienced with high numbers of COVID-19 cases and found that age, symptoms, comorbid diseases, chest CT, laboratory findings of inflammation are significant predictors for admission to hospital. Therefore, these risk factors should consider routinely for patients with a high risk of developing severe and critical diseases by clinicians.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course andrisk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395: 1054-62.doi: 10.1016/S0140-6736(20)30566-3.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: 10.1016/S0140- 6736(20)30183-5.
YangW, Cao Q, Qin L,Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80:388-93. doi: 10.1016/j.jinf.2020.02.016.
Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta analysis. J Med Virol. 2020;92(9):1449-59. doi: 10.1002/jmv.25822.
Guan WJ, Ni ZY, Hu Y, Wen-hua L, Chun-quan O, Jian-xing H, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: 10.1056/ NEJMoa2002032.
Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(7):504-12. doi: 10.1086/432007.
Cheng D, Calderwood C, Skyllberg E, Ainley A. Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: A retrospective cohort analysis. BMJ Open Resp Res. 2021;8(1):e000813. doi: 10.1136/ bmjresp-2020-000813.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41. doi: 10.1111/all.14238.
Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019 nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5):2000062. doi: 10.2807/1560-7917. Es.2020.25.5.2000062.
Lin YF, Duan Q, Zhou Y, Yuan T, Li P, Fitzpatrick T, et al. Spread and impact of COVID-19 in China: A systematic review and synthesis of predictions from transmission-dynamic models. Front Med (Lausanne). 2020;7:321. doi: 10.3389/fmed.2020.00321.
Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China-key questions for impact assessment. N Engl J Med. 2020;382(8):692-4. doi: 10.1056/NEJMp2000929.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585.
Biscayart C, Angeleri P, Lloveras S, Chaves T, Schlagenhauf P, Rodriguez-Morales AJ. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give
to travellers? Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI). Travel Med Infect Dis 2020:101567. doi: 10.1016/j.tmaid.2020.101567.
Li T, Lu L, Zhang W, Tao Y, Wang L, Bao J, et al. Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China. Arch Gerontol Geriatr. 2020;91:104185.
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.doi: 10.1016/j.ijantimicag.2020.105924.
Petrilli CM, Jones SA, Yang J. Factors associated with hospital admission and critical illness
among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ 2020;369:1966. doi: 10.1136/bmj.m1966.
Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8:436-8. doi:10.1016/S2213-2600(20)30167-3.
Li Y, Yao L, Li J, Chen L, Song Y, Cai Z, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020;92(7):903-8. doi: 10.1002/jmv.25786.
Sümer Ş, Ural O, Nazlım AD, Çiftçi Ş, Türkseven B, Kılınçer A, et al. Clinical and laboratory characteristics of COVID-19 cases followed in Selçuk University Faculty of Medicine. Klimik J. 2020;33(2):122-7. doi: 10.5152/kd.2020.26.
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. AJR Am J Roentgenol. 2020;215(1):87-93. doi: 10.2214/AJR.20.23034.
Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428-55. doi: 10.1111/all.14657.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. doi:10.1001/jama.2020.6775.
Zeng F, Deng G, Cui Y, Zhang Y, Dai M, Chen L, et al. A predictive model for the severity of COVID-19 in elderly patients. Aging (Albany NY). 2020;12(21):20982-96. doi: 10.18632/aging.103980.
Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor shortterm outcome. J ClinVirol. 2020;127:104354. doi: 10.1016/j.jcv.2020.104354.
Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, et al. The outcome of COVID 19 in patients with hematological malignancy. J Med Virol. 2021;93(2):1099-104. doi: 10.1002/jmv.26404.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020;55:2000547. doi: 10.1183/13993003.00547-2020.
Zhang ZL, Hou YL, Li DT, Li FZ. Laboratory findings of COVID-19: A systematic review and metaanalysis. Scand J Clin Lab Invest. 2020;80(6):441-7. doi: 10.1080/00365513.2020.1768587.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623.
How to Cite
Copyright (c) 2022 Holistence Publications
This work is licensed under a Creative Commons Attribution 4.0 International License.
When the article is accepted for publication in the HSQ authors transfer all copyright in the article to the Holistence Academy Ar-Ge Yazılım Yayıncılık Eğitim Danışmanlık ve Organizasyon Ticaret Ltd. Şti.The authors reserve all proprietary right other than copyright, such as patent rights.
Everyone who is listed as an author in this article should have made a substantial, direct, intellectual contribution to the work and should take public responsibility for it.
This paper contains works that have not previously published or not under consideration for publication in other journals.